Linda Stein Gold mentions in a video posted on Skin and Allergy News, referring to Galderma’s Ivermectin Cream ;
- Phase 3 Clinical Trials have completed, and
- FDA Approval is expected later this year (2014).
This is great new for those who 1) want to try an approved treatment for demodex mites and 2) may not be happy with their usage of Metrogel.
The clinical trial data suggests that after 14 days of treatment, the treatment was starting to work and after 4 weeks, 30% of patients were reported to be clear of the papules and pustules of rosacea.
Ivermectin is being described as safe and effective. Indeed this interview suggests that the Ivermectin cream may have less side effects that the vehicle that carries the active molecule!
Ivermectin is said to have 2 methods of action – anti inflammatory and its parasitic actions against demodex.
Mar 23, 2014
Video recorded as part of the AAD Annual Meeting in Denver, CO.
Dr. Stein Gold was a clinical investigator for the trial and is a consultant for Galderma.